Heart Failure Management Approach

Diagnostic Evaluation

The American Heart Association recommends arranging urgent echocardiography within 2 weeks to assess left ventricular ejection fraction (LVEF), cardiac structure, and function, as this single test determines all subsequent management 1, 2
A BNP level of 160 pg/mL exceeds the 100 pg/mL threshold for cardiac causes of symptoms, but remains below 400 pg/mL, placing this in an intermediate diagnostic zone that requires cardiac imaging for definitive assessment 2
The American College of Cardiology suggests that a BNP level of 160 pg/mL, combined with leg swelling, suggests possible heart failure but could also reflect other conditions 3, 4

The European Society of Cardiology recommends obtaining a complete metabolic panel, including serum electrolytes, BUN, and creatinine, to assess renal function and electrolyte status 4, 2
A complete blood count is recommended to evaluate for anemia, which can worsen heart failure 4
Thyroid-stimulating hormone should be checked, as thyroid dysfunction can cause or exacerbate heart failure 4
Liver function tests are recommended to assess hepatic congestion 4
Urinalysis should be performed to check for proteinuria, suggesting nephrotic syndrome 4
A 12-lead ECG is recommended to look for ST-T abnormalities, low voltage, or conduction abnormalities 4

The American Heart Association recommends immediately initiating quadruple guideline-directed medical therapy for patients with HFrEF (LVEF ≤40%), including ACE inhibitor or ARB, beta-blocker, mineralocorticoid receptor antagonist, and loop diuretic only if clinical fluid overload is present 1, 2
For patients with HFpEF (LVEF >40%), diuretics should be used for symptom relief only if fluid overload is clinically present, and focus should be on treating underlying conditions 1, 4

BNP levels parallel NYHA functional class severity, and higher BNP after treatment predicts worse outcomes (mortality and HF readmissions) 4
Each 500 pg/mL increase above baseline increases mortality risk by 3.8% 1
At 160 pg/mL, prognosis depends heavily on echocardiographic findings and treatment response 2